About Civica
Civica is a 501(c)(4) social welfare organization established in 2018 by health systems and philanthropies to reduce chronic generic drug shortages and related high prices in the United States. Civica is led by an experienced team of healthcare and pharmaceutical industry leaders.
Today, more than 55 health systems have joined Civica. They represent over 1,500 hospitals and one-third of all U.S. hospital beds. Civica has also begun to supply the U.S. Department of Veteran's Affairs, the U.S. Department of Defense and the U.S. Strategic National Stockpile of essential medicines.
Civica recently announced plans to expand its mission, via a unit called CivicaScript, to into the outpatient pharmacy space and to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market. The availability of Civica's affordable insulins, beginning in 2024, will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out of pocket for their medications.
Civica's mission is to ensure that quality generic medications are accessible and affordable to everyone. Since established, the #1 Policy for the Civica team has been "Do What Is in the Best Interest of Patients." Civica's manufacturing facility in Petersburg, Virginia, is the future home of affordable insulin and essential sterile injectable medicines. The facility is currently in late-stage construction and hiring for the site is well-underway.
To find out more about how Civica's innovative model is directly impacting patient care, click here to read a summary from the New England Journal of Medicine. (https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0189)
To learn more about Civica's plans to bring affordable insulin to Americans living with diabetes, click here to read an article in BioSpace.
(https://www.biospace.com/article/civica-is-rallying-leaders-to-make-insulin-affordable-by-2024-/)
Job Description
This position will play a crucial role in workforce planning and staff development at the Petersburg, VA manufacturing site. The Workforce Development Program Manager is responsible for designing and implementing strategies to identify staffing needs and to enhance the skills, knowledge, and performance of the workforce.
Basic Qualifications and Capabilities:

• A minimum of 7 years of relevant industry experience including demonstrated experience in workforce development and training within the pharmaceutical industry.
• Minimum of Bachelor's degree from a fully accredited institution.
• Experience working in sterile manufacturing, cleanroom, and cGMP environments that meet FDA, ICH guidelines, local regulations, and industry best practices.
• Experience developing staffing and training plans.
• Demonstrated ability to work in a fast-paced team environment, meet deadlines, and prioritize work. Start-up experience preferred.
• Excellent oral and written communication skills, including presentations.
• Advanced computer skills with working knowledge of MS Project, Office, Word, Excel, PowerPoint, Etc.

Preferred Qualifications:

• Degree and/or certification(s) focusing on adult learning principles and/or Train the Trainer programs
• Veeva Vault Learning Module management experience
• Experience with content creation via e-learning design tools such as SCORM, Articulate, etc.